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Abstract: The aim of this study was to design and manufacture
an easily assembled cartilage implant model for auricular recon-
struction. First, the printing accuracy and mechanical properties
of 3D-printed poly-ε-caprolactone (PCL) scaffolds with varying
porosities were determined to assess overall material properties.
Next, the applicability of alginate as cell carrier for the cartilage
implant model was determined. Using the optimal outcomes of
both experiments (in terms of (bio)mechanical properties, cell
survival, neocartilage formation, and printing accuracy), a hybrid
auricular implant model was developed. PCL scaffolds with
600 μm distances between strands exhibited the best mechanical
properties and most optimal printing quality for further explora-
tion. In alginate, chondrocytes displayed high cell survival (~83%
after 21 days) and produced cartilage-like matrix in vitro. Alginate
beads cultured in proliferation medium exhibited slightly higher
compressive moduli (6 kPa) compared to beads cultured in chon-
drogenic medium (3.5 kPa, p > .05). The final auricular mold
could be printed with 300 μm pores and high fidelity, and the
injected chondrocytes survived the culture period of 21 days. The
presented hybrid auricular mold appears to be an adequate
model for cartilage tissue engineering and may provide a novel
approach to auricular cartilage regeneration for facial reconstruc-
tion. © 2018 The Authors Journal of Biomedical Materials Research Part
B: Applied Biomaterials published by Wiley Periodicals, Inc. J Biomed
Mater Res B Part B: 00B: 000–000, 2018.
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INTRODUCTION
Auricular reconstruction following trauma (e.g., burns), cancer,
or congenital anomalies is a very challenging procedure. To
date, several treatment options exist to reconstruct a deformed
auricle including synthetic implants (e.g., Medpor)1–3 and
autologous reconstruction using rib cartilage.4–6 However,
both techniques have several limitations including donor
site morbidity,7,8 risk of implant exposure,1,9 and surgical
complexity.10,11
Tissue engineering, in combination with novel biofabrica-
tion strategies, is a promising solution to engineer auricular
implants with patient-derived donor cells.12–15 These biofab-
ricated auricular constructs could ultimately function as
patient-specific implants for the reconstruction of a
deformed auricle.
Successful engineering of a clinically relevant auricular
cartilage implant requires a scaffold that provides a three-
dimensional (3D) environment to support cell and tissue
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growth. The optimal scaffold ideally matches the native
properties of cartilage extracellular matrix (ECM) and is
mechanically strong, porous, and biodegradable.16,17 Unfor-
tunately, creating such a construct is still a major challenge
in the field of tissue engineering. In addition, efforts to trans-
late engineered cartilage to the clinic have been hampered
by problems associated with scaling up.18 3D printing can
aid in both the production of 3D scaffolds that closely mimic
the ECM of cartilage in terms of biomechanical properties
and in producing larger, anatomically shaped tissues such as
whole auricles. One strategy to engineer cartilage using 3D
printing is to directly deposit the cells in a layer-by-layer
fashion. The “bioink” that is required to directly deposit such
cells consists of a synthetic, or more commonly, natural
hydrogel mixed with cells.19 Although hydrogels can closely
resemble the native ECM of cartilage, the mechanical
strength of such gels is low.20 Therefore, hydrogels often
require a synthetic supporting scaffold or microfibers that
temporarily increase the mechanical properties.21,22 These
supporting scaffolds can be co-printed with the hydrogel to
form an integrated scaffold construct.
Another common strategy to engineer cartilage using 3D
printing is to print the supporting scaffold and manually
load the cell-hydrogel mixture onto the 3D-printed scaffold,
traditionally known as “top-down” approach.23 Using this
strategy, cells must deposit their own ECM on the prefabri-
cated scaffold. A commonly used polymer for creating such a
supporting scaffold is poly-ε-caprolactone (PCL). PCL is a
promising biopolymer for tissue engineering due to its tun-
ing possibility, chemical versatility, and strength,24 and has
been used in a clinical setting.
In a previous study, our group introduced the cage con-
struct.25 In that study, we developed a 3D-printed construct
with a central core consisting of a natural polymer with cells,
and an outer synthetic PCL cage for mechanical support. In
the current study, we aimed to take this construct one step
further by creating a clinically relevant and simplified two-
part scaffold construct that can be easily assembled in the
shape of human auricular cartilage. First, we tested the
mechanical properties of both 3D printed PCL scaffolds and
alginate hydrogel beads and discs and tested the survival of
isolated chondrocytes inside the gel alone, with and without
additional chondrogenic stimulation. Subsequently, we com-
bined the two concepts by designing and 3D printing a two-
part PCL mold in the shape of human auricular cartilage and
injected this construct with a mixture of alginate and chon-
drocytes before culturing the final construct in vitro.
METHODS
Cell isolation and culture
Cell expansion. Cell isolation and culture of chondrocytes
was performed as described previously.25 Briefly, cartilage
was obtained from the ears (n = 4) of sacrificed Dutch milk
goats acquired from a local abattoir. The dissected cartilage
was treated with 0.2 wt % type II collagenase (Roche diag-
nostics, Almere, the Netherlands) under gentle agitation at
37C for 16 h to isolate the chondrocytes from the cartilage
tissue. The digested tissue was subsequently filtered using a
40 μm-mesh to remove residual ECM, pelleted using centri-
fugation, and washed with PBS. The resulting cell suspension
was cultured in GIBCO Dulbecco’s modified Eagle’s medium
(DMEM; Life Technologies, Thermo Fisher Scientific, Wal-
tham, MA, USA) supplemented with 10% fetal bovine serum
(FBS; Hyclone-Thermo Scientific, Thermo Fisher Scientific,
Waltham, MA, USA), 1% PSF (10,000 U/mL Penicillin,
10 mg/mL Streptomycin, 25 mg/mL Amphotericine B
(Fungizone; Millipore Sigma, St. Louis, MO, USA), and 50 μg/
mL L-(+) ascorbic acid (Merck, Darmstadt, Germany) (prolif-
eration medium). When cell cultures reached 80% conflu-
ence, chondrocytes were trypsinized using 0.05% trypsin–
EDTA, resuspended in cryoprotective medium (Recovery
Freezing Medium, Life Technologies, Thermo Fisher Scien-
tific, Waltham, MA, USA), and stored in liquid nitrogen until
further use. All chondrocytes taken from liquid nitrogen
were cultured up to passage three (P3) in proliferation
medium to allow sufficient cells for three-dimensional
(3D) culture in alginate hydrogel.
3D culture in alginate hydrogel beads. Sterile alginate solu-
tion was prepared by dissolving ultrapure sterile sodium
alginate (MW 150–250 kDa, Pronova SLG100, Novamatrix,
FMC Biopolymer, Sandvika, Norway) in 0.9 wt % Sodium
Chloride (NaCl). The resulting alginate solution was vortexed
at high speed and subsequently kept at room temperature
for at least 1 h to minimize bubbles in the solution. For 3D
alginate culture, cultured auricular chondrocytes were
slowly suspended at a density of 4 × 106 cells/mL in 3 wt %
alginate solution and transferred into 10 mL sterile syringe.
The suspension was slowly passed through a 21-gauge
(21G) needle to produce small drops, which fell into a sterile
102 mM CaCl2 solution to allow instantaneous gelation. Fol-
lowing gelation, the beads were allowed to further gelate for
10 min in CaCl2 solution before being washed with 0.9 wt %
NaCl and transferred to a 24-well plate.
Beads were cultured in either proliferation medium
(as described in Cell Expansion) or chondrogenic medium.
Chondrogenic medium consisted of DMEM supplemented
with 1% FBS, 1% PSF, 50 μg/mL L-(+) ascorbic acid, with
added 1× Insulin Transferrin Selenium (ITS, Sigma-Aldrich)
and 10 ng/mL transforming growth factor β1 (TGF-β1; R&D
systems, Minneapolis, MN). Beads were cultured in vitro for
21 days and processed for LIVE/DEAD (Thermo Fisher Sci-
entific, Waltham, MA) analysis, (immuno)histological analy-
sis, and biomechanical analysis. Culture medium was
changed twice a week.
PCL scaffold design and fabrication
PCL scaffolds. Three-dimensional scaffolds with five differ-
ent distances between strands (400 μm, 600 μm, 800 μm,
1000 μm, and 1200 μm) were designed using an in-house
custom software that generated 3D-printing control code (G-
code) and printed using PCL on a 3DDiscovery printer
(RegenHU, Switzerland). Medical-grade PCL (Purasorb PC12;
Corbion, Purac Biomaterials) was extruded (HM-300H
thermo polymer extruder, RegenHU; extrusion rate 18 revo-
lutions/m) through a preheated needle (ø300 μm; 80C) at
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0.2 MPa (2 bar) and plotted in a layer-by-layer fashion at
5 mm/s. For smaller porosities, the extrusion rate was
adjusted to ensure open porosity.
Auricular cartilage mold. An auricular cartilage mold, based
on the parametric model described in the study by Bos
et al.,26 was designed in CATIA V5 software (Dassault sys-
temes, Vélizy-Villacoublay, France). The two-part mold was
processed in the custom software (see above) to obtain a
controllable G-code for 3D printing. Using the optimal poros-
ity from the above experiment, the auricular mold was then
printed in two parts on the 3DDiscovery printer using the
same settings as described previously. Following 3D printing,
the molds were disinfected in 70% ethanol for 1 h, washed
3 times with sterile PBS, and air-dried in a sterile incubator.
Following disinfection, all mold parts were transferred to
individual petri dishes and coated with sterile gelatin (10%,
Merck KGaA, Darmstadt, Germany) to block the pores and
generate a sealed mold. After gelation of the gelatin solution
at room temperature, 400 μL of the cell-alginate mixture
(same suspension as described in 3D culture in alginate
hydrogel beads) was injected into the bottom part of the
mold, crosslinked for 2 min using 102 mM CaCl2, and
directly closed by placing the top part of the mold. Upon
subsequent immersion into proliferation medium at 37C,
the gelatin liquefied and vacated the pores to allow nutrient
and oxygen exchange through the mold pores. Figure 1A
provides a complete overview of the fabrication process. The
complete auricular implant models (Fig. 1B) were cultured
in vitro in proliferation medium at 37C, 5% CO2 for 21 days
and processed for LIVE/DEAD staining.
Microscopy
Optical microscopy (5× Objective, Nikon Eclipse LV100ND,
Tokyo, Japan) was performed to assess the microscopic archi-
tecture of the 3D printed PCL scaffolds. Scaffolds were imaged
from the top, bottom, and side view and processed in accompa-
nying software (NIS-Elements, Nikon). The overall structure of
the 3D printed PCL scaffolds was assessed with a stereoscopic
microscope (Nikon SMZ-10) with a digital camera (Nikon
DXM1200F) and fiber optic light source (Schott, KL1500-T).
A Light sheet microscope (UltraMicroscope II, LaVision
BioTec GmbH, Bielefeld, Germany) equipped with a white
light laser (SuperK EXTREME, NKT photonics; excitation
400–800 nm) and cMOS camera (Neo, Andor) and a Nikon
Eclipse 80i confocal microscope were used to image chon-
drocyte-laden alginate beads and chondrocyte-laden alginate
taken out of the auricular implant model respectively. The
beads were placed in a holder and submerged in PBS during
imaging. In general, the light sheet microscope has good
optical sectioning capabilities allowing Z-plane imaging of
intact hydrogels. However, light only penetrates a few hun-
dred micrometers into transparent tissues.27
Cell viability analysis and quantification
A LIVE/DEAD viability/cytotoxicity kit (L3224; Thermo
Fisher Scientific) was used to assess cell viability in chondro-
cyte-laded alginate beads according to manufacturer’s
instructions. Briefly, chondrocyte-laden alginate beads were
washed in PBS, followed by incubation in 0.5 μL/mL Cal-AM
and 2 μL/mL Eth-D (Thermo Fisher) in PBS at 37C for
1.5 h. Beads were washed again in PBS and imaged using
light sheet or confocal microscopy. Live and dead cell
FIGURE 1. (A) Schematic of steps in the biofabrication of the implant model. (B) Schematic of the study methods. First, alginate hydrogel beads and
3D-printed PCL scaffolds were analyzed individually. Next, alginate and PCL were combined in one construct to develop an auricular implant model.
PCL: Poly-ε-caprolactone.
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quantification was performed in ImageJ v1.47 for Mac using
the “process > find maxima” function.
Cell quantification in alginate beads cultured in prolif-
eration and chondrogenic medium was performed using
DAPI staining. Unfixed chondrocyte-laden alginate beads
were covered in Tissue-Tek, snap frozen, and cut in 20 μm
sections using a cryostat. Following the application of
mounting medium (Fluoroshield Mounting Medium with
DAPI; Abcam), beads (n = 3 per group) were imaged on a
Nikon Eclipse 80i confocal microscope. Cells were counted
in NIS-Elements AR software (v 3.2; Nikon Instruments
Europe B.V). Both the total number of cells and percent
(%) cells per bead were calculated per section.
Histology and immunohistochemistry
For histology and immunohistochemistry (IHC), unfixed
chondrocyte-laden alginate beads were covered in Tissue-
Tek (Thermo Fisher), snap frozen in liquid nitrogen, and
cut in 14–20 μm sections at −20C using a cryostat. Sec-
tions were mounted on Superfrost Plus Gold microscopic
slides (Thermo Scientific) and stained with Alcian Blue
(pH 1.0) for histological examination or processed for IHC.
For IHC, sections were incubated for 2 h with monoclonal
antibodies against type II collagen (II-II6B3, Developmen-
tal Studies Hybridoma Bank) or type VI collagen
(MAB3303, EMD Millipore). Following incubation, sections
were washed in PBS and incubated for 30 min with EnVi-
sion (Dako). Finally, sections were incubated with AEC
substrate for 10 min and visualized using microscopy.
Postprocessing was undertaken using NIS Elements soft-
ware (Nikon Instruments Europe B.V.).
Control cartilage samples derived from goat ears were
embedded in paraffin using standard histological tech-
niques, cut in 5 μm sections, and stained using Alcian Blue,
Mayer’s Hematoxylin-Eosin, type II and type VI collagen to
assess glycosaminoglycan distribution, morphology, and
FIGURE 2. CAD view, gross view, and microscopic views of 3D-printed PCL scaffolds with varying distances between strands. S represents the sam-
ple, with the number representing the distances between strands in micrometers (μm).
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collagen distribution, respectively (Supporting Information
Fig. S1).
(Bio)mechanical analysis
PCL scaffolds. The mechanical properties of PCL scaffolds
with varying distances between strands (400–1200 μm; n = 5
per group) were analyzed using mechanical compression
testing according to the ASTM standard D695. The 3D-
printed PCL blocks were cut into six cuboids (5 mm wide ×
5 mm wide × 10 mm high) using a new blade for each sam-
ple. An Instron 5969 machine with a 5 kN load cell was used
to compress unconstrained samples between two steel
plates at a rate of 1 mm min−1 to 33% strain. Five samples
were tested for each scaffold design (porosity). Compressive
moduli were calculated for all samples using a linear-elastic
compression phase as the applied force increased from
10 to 50 N.
Alginate hydrogel. For mechanical characterization of empty
and chondrocyte-laden alginate beads after in vitro cell cul-
ture, compression was performed using a Physica MCR
501 rheometer (Anton Paar, GmbH, Austria). The gap
between the plates was lowered from 2 mm to 0.1 mm at a
rate of 0.001 mm s−1 and the resulting normal force from
the sample on the top plate was recorded. To determine the
storage (G’) and loss (G”) shear moduli, small-amplitude
oscillatory shear (SAOS) rheometry at a frequency of 0.5 Hz
and with a strain amplitude of 0.5% was performed on
2 mm (height) × 20 mm (diameter) chondrocyte-laden algi-
nate disks that were created using a 3D printed mold. All
samples were tested at 37C using PP20 stainless steel
geometry (parallel plates, 20 mm diameter).
Statistical analysis. Data were analyzed using GraphPad
Prism version 6.02 (Graphpad Software). Data are repre-
sented as Mean  Standard Deviation (SD) unless otherwise
indicated. Statistical analysis was performed using unpaired
t-tests or one-way analysis of variance (ANOVA) with multi-
ple comparisons. Chondrocytes proliferation and storage/
loss modulus of chondrocyte-laden alginate beads and disks
were analyzed using unpaired t-tests, while ANOVA was
used for comparing the compressive moduli of 3D printed
PCL scaffolds. A p value of <0.05 was considered statistically
significant.
RESULTS
Structural properties of 3D-printed PCL. The structural
properties of 3D-printed PCL scaffolds were determined by
examining the surface porosity and mechanical properties.
Macroscopic analysis of the PCL scaffolds showed good
printing quality (Fig. 2, gross view). However, microscopic
analysis of individual PCL strands showed some variance in
FIGURE 3. Mechanical analysis and pore size analysis of 3D-printed PCL scaffolds with varying distances between strands. (A) Mean compressive
modulus (MPa) of PCL scaffolds with varying porosities. S(number) = sample (distance between strands). (B) Force – displacement curves of PCL scaffolds
with varying porosities. (C) Average pore width (mm) and surface pore fraction (0–1) of 3D-printed PCL scaffolds. To allow for open porosity, the
S400 and S600 scaffolds were printed using a lower extrusion rate (10 and 15 revs/m, respectively). (D) Illustration of pore (mm) width and surface
pore fraction (%) measurement. (E) Direction of axial compression of PCL scaffolds. *p < 0.05, ****p < 0.001.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B | MONTH 2018 VOL 000B, ISSUE 0 5
ORIGINAL RESEARCH REPORT
strand diameter over a short distance (Fig. 2, microscopic
view). In addition, the lateral view of the scaffold showed a
large variety in pore width (Fig. 2, side view). Overall, the
smaller the pore width, the more accurate the 3D-printed
scaffold. Specifically, the S400 and S600 showed qualitatively
more repeatable pores than S800-S1200 (Fig. 2).
The compressive modulus was highest in the scaffolds
with the smallest pore fraction (Fig. 3A). The compressive
modulus of S600 and S800 did not significantly differ from
S400 (p = 0.91 and p = 0.07, respectively). To ensure pores
were not blocked, the S400 and S600 scaffolds were printed
with lower extrusion rates (decreasing the overall strand
thickness) of 10 and 15 revs/m, respectively, as opposed to
18 revs/m for other samples. This may have caused a slight
decrease in compressive modulus, as well as increase in sur-
face pore fraction (Fig. 3C). Nevertheless, there was an over-
all trend that the higher the pore size and pore fraction, the
lower the mechanical properties. The surface pore fraction
however, calculated as the percentage of open space versus
total area (Fig. 3D), was notably lower in scaffolds with
smaller pores (Fig. 3C): the surface pore fraction of S400
and S600 were approximately 30%, whereas the surface
pore fraction of S1000 and S1200 reached approximately
50% (Fig. 3C).
Cell viability and proliferation in alginate hydrogel beads.
Chondrocyte-laden alginate hydrogel beads were evaluated
for cell survival and proliferation after 21 days of cell
culture. In proliferation medium, cells displayed a rounded
morphology and were dispersed throughout the alginate
hydrogel beads, with more cells found at the edges of the
beads (Figs. 4A and 5A). In chondrogenic medium, cells were
also dispersed throughout the alginate, but in multiple cell
clusters (Figs. 4A and Fig. 5B). Cell survival was high in both
proliferation and chondrogenic medium (82.67%  2% and
82.40%  2%, respectively, p = 0.88, Fig. 4B). Both the total
number of cells (Fig. 5C), and area of cells (%) were higher
in beads cultured in chondrogenic medium compared to pro-
liferation medium (p < 0.05).
Hydrogel biomechanical properties. The biomechanical
properties of chondrocyte-laden alginate hydrogels (beads
and discs) were tested using compression tests and SAOS
rheometry. The overall normal force of the chondrocyte-laden
alginate beads following compression is shown in
Fig. 6A. Beads cultured in proliferation medium exerted
higher forces (0.24 N) at 1 mm gap (~50% strain) than con-
trol beads (without cells) (0.06 N) and beads cultured in
chondrogenic medium (0.07 N) following a culture period of
21 days.
We next tested the elastic shear modulus (G’) of chon-
drocyte-laden alginate disks after 28 days of culture in dif-
ferent culture media. The elastic modulus of discs cultured
in proliferation medium (6100  1925 Pa) was higher
than the elastic modulus of discs cultured in chondrogenic
medium (3423  1092 Pa), although the difference was
FIGURE 4. (A) Representative LIVE/DEAD stains of alginate beads with chondrocytes after 21 days of culture in “proliferation” medium and “chon-
drogenic” medium (additional TGF-β and ITS premix). Green represents live cells, magenta represents dead cells. Blurring in the center of the
“chondrogenic” alginate bead is due to limited light penetration in the 3D construct. (B) Quantification of live and dead cells in alginate beads cul-
tured in “proliferation” and “chondrogenic” medium.
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not statistically significant (p = 0.104), Figure 6B. Alginate
discs without cells cultured in proliferation medium
showed an average elastic modulus of 4163  1111 Pa
(Fig. 6B).
Neocartilage formation. The production of glycosaminogly-
cans, type II collagen, and type VI collagen were assessed in
chondrocyte-laden alginate beads (Fig. 7). In proliferation
medium, chondrocytes deposited some pericellular and territo-
rial glycosaminoglycans, while in chondrogenic medium, there
was pericellular, territorial, and interterritorial deposition of
glycosaminoglycans. Native auricular cartilage showed mostly
pericellular and territorial glycosaminoglycans, with some inter-
territorial glycosaminoglycans (Supporting Information Fig. S1).
FIGURE 5. Chondrocyte proliferation after 21 days of culture in proliferation and chondrogenic medium. (A) DAPI stain of alginate bead in prolifera-
tion medium (cryosection; 20 μm). (B) DAPI stain of alginate bead in chondrogenic medium (cryosection; 20 μm). C) Mean  SD of cells per
section (%) in proliferation and chondrogenic medium. (D) Mean  SD of cells per section (#) in proliferation and chondrogenic medium.
n = 3, **p < 0.05.
FIGURE 6. (A) Normal force of control beads and alginate beads cultured in proliferation and chondrogenic medium. n = 3, no statistically significant
differences found (p > 0.05) between control disks, and disks cultured in proliferation and chondrogenic medium. (B) Mean  SEM of storage and
loss modulus in control alginate disks and chondrocyte-laden disks cultured in proliferation and chondrogenic medium for 28 days.
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After 21 days, type II collagen produced by chondro-
cytes in beads cultured in proliferation medium was
deposited mostly in the pericellular region. Chondrogenic
medium stimulated some additional deposition in territo-
rial and interterritorial regions (Fig. 7). Type VI collagen
deposition was mostly pericellular in both proliferation
and chondrogenic medium. However, large cell clusters in
chondrogenic medium seemed to have formed some
territorial matrix. In native auricular cartilage, type VI col-
lagen, although most dense in the pericellular/territorial
region, appeared rather dispersed throughout the whole
tissue (Supporting Information Fig. S1).
Auricular implant model. To assess the feasibility of devel-
oping an auricular implant model, both PCL and alginate
were combined in one construct. From the above
FIGURE 7. Histological and Immunohistological analysis of chondrocyte-laden alginate beads.
FIGURE 8. (A) Gross view of the PCL-alginate auricular implant model. Alginate can be found inside the grooves of the PCL mold. Note that one part
of the 2-part mold has been taken off for viewing. (B) in vitro cultured PCL-alginate auricular implant models. (C) LIVE/DEAD stain of alginate taken
out of the PCL mold after 21 days of culture. High-cell survival was seen throughout the entire implant model.
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experiments (Figs. 2 and 3), a porosity of 300 μm (S600)
was chosen for the auricular implant model because it dem-
onstrated both a high compressive modulus and repeatable
pore geometry. The two-part auricular mold (Figs. 1 and 8A,
B) could be printed with high fidelity. The final size of the
assembled PCL mold was 40 mm (height) × 25 mm (width)
× 6 mm (thickness). After the in vitro culture period in pro-
liferation media for 21 days, the top mold could be removed
easily without alginate sticking to the PCL. After removal
(Fig. 8A), the alginate was seen to be evenly distributed in
the grooves of the PCL mold. The size of the mold did not
change during in vitro culture. Cell survival was high
(>85%) in the alginate gel after 21 days of culture at all
positions in the construct (Fig. 8C). The cells preferred the
alginate as microenvironment as opposed to the surrounding
PCL; very few cells attached to the PCL scaffold. Further-
more, cells were distributed evenly both throughout the
model and in the alginate hydrogel.
DISCUSSION
Advances in the field of tissue engineering and biofabrication
provide a possibility to overcome current issues in auricular
cartilage reconstruction. One of these issues is creating an
implant model that both mimics the complexity of the auricle
and maintains this complexity during cellular growth and tis-
sue remodeling. In the current study, we developed and
tested a biofabricated auricular implant model in vitro, that
can be used for ear reconstruction.
Appropriate selection of the biomaterials is vital for the
long-term success of implants.28 In this study, PCL was used
because of its inherent strength for potential subcutaneous
in vivo implantation,13 high elasticity,29,30 and low-melting tem-
perature of 60C, making it an excellent biomaterial for 3D
printing.31 3D-printed PCL scaffolds exhibited very high-
compressive moduli (100–200 MPa), depending on the poros-
ity (Fig. 3A).32 These compressive moduli are approximately
100 times higher than that of native auricular cartilage,33,34
and are similar to the clinical synthetic implant material porous
polyethylene (Medpor),10,34 which is widely used for auricular
reconstruction.3,35 The high stiffness of the PCL is both advan-
tageous for protection of the hydrogel as well as shape preser-
vation following possible implantation.36
Scaffold porosity is an important aspect in
biofabrication-based tissue engineering.37 For example, Med-
por constructs, with pores greater than 100 μm, allows soft
tissue and vascular ingrowth when implanted in patients.38
We found the optimal porosity in terms of mechanical prop-
erties, 3D design, and PCL material, to be 300 μm (S600)
(Fig. 3C). Although, 3D-printed scaffolds with smaller pore
sizes (S400) seemed more accurate (Fig. 2), some pores
were blocked, which would be expected to block nutrient
diffusion in the hydrogel. In addition, smaller pore sizes have
been shown to promote less tissue ingrowth than larger
pores.39
With regards to nutrient diffusion in the alginate hydro-
gel, beads cultured in both proliferation medium and chon-
drogenic medium displayed high cell survival after 21 days
in vitro (~83%). There are various reasons why cell survival
is not 100%, including chemical crosslinking with calcium
chloride,40 alginate viscosity,41 and cell culture conditions.42
Stimulation with chondrogenic medium did not increase the
percentage of cell survival but did significantly increase cell
proliferation and cluster formation (Fig. 5). Cell cluster for-
mation in 3D hydrogels has been shown previously,43–45 but
the mechanism by which cell clusters are formed is poorly
understood.46 Cell clustering could be induced by stimula-
tion with TGF-beta present in our chondrogenic medium.
However, this phenomenon is mostly seen in osteoarthritic
models.47,48 Nevertheless, a study by Cavo and colleagues49
showed that MCF-7 cells show high-cell proliferation, associ-
ated with cluster formation, in soft alginate hydrogels. In
addition, Mhanna and colleagues50 explain that alginate
inhibits cell migration and forces cells to proliferate in nodes
resulting in cell clusters. In this study, the compressive mod-
ulus of alginate beads stimulated with chondrogenic media
was lower while the proliferation rate was higher. Therefore,
proliferation rate might not only be related to hydrogel stiff-
ness, but also cluster formation.
The stiffness of in vitro cultured chondrocyte-laden algi-
nate beads was low (~5 kPa, Fig. 6B) compared to native
auricular cartilage (~1 MPa34). Although not statistically sig-
nificant, there was a noticeable difference in the elastic mod-
ulus of beads cultured in proliferation medium (~6 kPa)
compared to chondrogenic medium (~3.5 kPa). Although, we
expected that stimulation with TGF-beta would increase the
mechanical properties of the beads by increasing chondro-
cyte proliferation and matrix synthesis, the opposite was
found. This negative effect of continuous TGF-beta stimula-
tion has also been shown by others,51–53 which could sug-
gest that transient exposure of TGF-beta is important to
improve tissue formation.52
A study by Bhujbal and colleagues42 identified several
factors that may influence the overall mechanical stability of
alginate beads, including storage solution and cell load. They
showed that the mechanical properties of beads cultured in
DMEM decreased significantly. This might also explain the
low elastic moduli of our chondrocyte-laden alginate beads
in vitro. In addition, higher cell load could explain a lower
elastic modulus in chondrocyte-laden alginate beads stimu-
lated with TGF-beta (Fig. 5).
ECM deposition was more prominent in chondrocyte-
laden alginate beads cultured in chondrogenic medium.
Both glycosaminoglycans and type II collagen deposition
were higher in beads cultured in chondrogenic medium,
which is consistent with previous data.54–56 To determine
whether the pericellular matrix of auricular chondrocytes
was affected by TGF-beta stimulation, we performed type
VI collagen immunostaining. Type VI collagen was weakly
positive in the pericellular regions of both chondrocytes
stimulated with proliferation and chondrogenic medium,
which is consistent with a previous study on auricular car-
tilage macroaggregates.57 However, native auricular carti-
lage stained highly positive for VI collagen in both
pericellular and territorial matrix (Supporting Information
Fig. S1).
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Finally, to test the feasibility of printing an auricular
implant model that is easily injectable with hydrogel, we
combined both PCL and alginate in one construct. There are
numerous approaches to biofabrication-based auricular
reconstruction, most of which use a combination of hydro-
gels and thermoplastic polymers.14,15,58 Although, we also
used a combination of these materials, we applied a novel
approach by creating a two-part biodegradable 3D-printed
mold made from PCL that is easily assembled and injectable
using any type of hydrogel. Injected alginate allowed high
cell survival after 21 days of culture in the auricular mold
(Fig. 8). Auricular mold designs have been used previously
by other groups, but were difficult to fabricate and were not
integrated in the final engineered auricular tissue.7,36,51 The
novel hybrid implant model presented in this study may
have several advantages over other scaffold designs: (1) PCL,
which can cause inflammation when implanted in vivo,24 will
not be present in the maturing tissue, which in this design is
found inside the mold, (2) the mold design can have very
high mechanical properties without affecting the mechanical
properties of the maturing tissue, (3) the mold design can be
easily retrieved and disassembled after in vivo maturation59
as the mold offers a partial barrier between the maturing tis-
sue and native tissue, and (4) if necessary, the properties of
the PCL mold could be adjusted to decrease the degradation
rate, which can normally take up to 24 months.24 Making
use of these advantages, the mold design could then be used
as follows: (1) mold assembly, (2) in vivo implantation,
(3) tissue maturation, (4) retrieval of the implant model,
(5) disassembly of the outer mold, (6) reconstruction using
the matured cartilage tissue. Although, the auricular implant
model in this study was injected with chondrocyte-laden algi-
nate, the mold construct could be injected with any other
type of hydrogel and cell source, for example, with hydrogels
based on decellularized cartilage tissue.60–62
CONCLUSION
Here, we have described the process for engineering of a
hybrid auricular cartilage implant model for facial recon-
struction (see Fig. 1A). The hybrid implant model consists of
a porous synthetic outer mold with high mechanical proper-
ties required to overcome forces during in vivo tissue matu-
ration, and an inner “natural” core that consists of a
biomimetic environment for cartilage tissue formation. The
mold can be easily printed and assembled, while the design
makes it easy to inject any suitable hydrogel for tissue for-
mation. While long-term in vivo experiments are required to
test its preclinical applicability, the work presented in this
study provides a possible strategy for the use of biofabri-
cated tissue constructs in the clinic.
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